Giant Cell Arteritis (GCA)

Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis

Bosentan in the Treatment of Giant Cell Arteritis

Disease Activity Monitoring in Patients With Giant Cell Arteritis Study

Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone

The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis.

Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)

TArget Trial Emulation Comparing Effectiveness of Tocilizumab vs Methotrexate In Corticosteroid-Treated GCA Patients

A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis

Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica

Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.

Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment

Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)

oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound

Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients

Cardiac Involvement in Patients With Giant Cell Arteritis

Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis